Exeliom Biosciences

Exeliom Biosciences

Developing single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD54—82m (Dealroom.co estimates Jul 2023.)
Company register number 824343214
Dijon Bourgogne-Franche-Comté (HQ)
Authorizing premium user...